Evidence map›Paper›PMID 33559385›Full record

ArticlePediatric blood & cancer2021

Virtual visits as long-term follow-up care for childhood cancer survivors: Patient and provider satisfaction during the COVID-19 pandemic.

Lisa B Kenney, Lynda M Vrooman, Eileen Duffey Lind, Jill Brace-O'Neill, Jean E Mulder, Larissa Nekhlyudov, Christopher J Recklitis

Open access · bronzeAbstract read
In one paragraph

Article in Pediatric blood & cancer, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
11.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Cancer survivorship programs at the Dana-Farber Cancer Institute.Journal of cancer survivorship : research and practice · 2024
    Review
  8. Review
  9. Rural, Large Town, and Urban Differences in Optimal Subspecialty Follow-up and Survivorship Care Plan Documentation among Childhood Cancer Survivors.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2023
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Impact of COVID-19 on Pediatric Immunocompromised Patients.Pediatric clinics of North America · 2021
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Lisa B KenneyDavid B. Perini Jr., Quality of Life Clinic, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.ORCID https://orcid.org/0000-0002-2407-2522
Lynda M VroomanDavid B. Perini Jr., Quality of Life Clinic, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Eileen Duffey LindDavid B. Perini Jr., Quality of Life Clinic, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Jill Brace-O'NeillDavid B. Perini Jr., Quality of Life Clinic, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Jean E MulderDavid B. Perini Jr., Quality of Life Clinic, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Larissa NekhlyudovDavid B. Perini Jr., Quality of Life Clinic, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Christopher J RecklitisDavid B. Perini Jr., Quality of Life Clinic, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Harvard University · USDana-Farber Cancer Institute · USBrigham and Women's Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Telemedicine can potentially meet objectives of long-term follow-up care (LTFU) for childhood cancer survivors (CCS) while reducing barriers. We surveyed providers at our institution about their satisfaction with video-conference virtual visits (VV) with 81 CCS during COVID-19 restrictions. The same 81 CCS (or parent proxies) were surveyed about their experience, of which 47% responded. Providers and CCS were highly satisfied with VV (86% and 95% "completely/very satisfied," respectively). CCS rated VV "as/nearly as" helpful as in-person visits (66%) and 82% prefer VV remain an option postpandemic. High levels of survivor and provider satisfaction with VV support ongoing investigation into implementation for LTFU.

Indexed as

Cancer SurvivorsTelemedicineAdolescentAdultChildCOVID-19FemaleFollow-Up StudiesHematologic NeoplasmsHumansMalePatient SatisfactionYoung Adultchildhood cancer survivorCOVID-19telemedicine

Identifiers

PMID33559385
PMCPMC7995169
OpenAlexW3128068934

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.